AKTUELLE RHEUMATOLOGIE

Scope & Guideline

Empowering professionals with cutting-edge rheumatology insights.

Introduction

Explore the comprehensive scope of AKTUELLE RHEUMATOLOGIE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore AKTUELLE RHEUMATOLOGIE in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN0341-051x
PublisherGEORG THIEME VERLAG KG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1978 to 2024
AbbreviationAKTUEL RHEUMATOL / Aktuelle Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRUDIGERSTR 14, D-70469 STUTTGART, GERMANY

Aims and Scopes

AKTUELLE RHEUMATOLOGIE focuses on advancing the understanding and treatment of rheumatic diseases through rigorous research and clinical studies. The journal encompasses a broad spectrum of topics related to rheumatology, including pathophysiology, treatment modalities, and patient management strategies.
  1. Exploration of Disease Mechanisms:
    The journal emphasizes research that investigates the underlying mechanisms of various rheumatic diseases, aiming to uncover novel pathophysiological insights that can inform treatment strategies.
  2. Clinical Trials and Treatment Efficacy:
    AKTUELLE RHEUMATOLOGIE publishes studies evaluating the efficacy and safety of new and existing therapies for rheumatic conditions, including biologics and traditional disease-modifying antirheumatic drugs (DMARDs).
  3. Patient-Centered Research:
    The journal features research on patient outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases, highlighting the importance of patient perspectives in clinical practice.
  4. Comorbidities and Risk Factors:
    Research on the comorbidities associated with rheumatic diseases, including cardiovascular risks and mental health issues, is a core focus, emphasizing the need for comprehensive care approaches.
  5. Innovative Diagnostic Approaches:
    The journal encourages studies that advance diagnostic methods, including imaging techniques and biomarkers, to improve early detection and monitoring of rheumatic diseases.
  6. Interdisciplinary Collaboration:
    AKTUELLE RHEUMATOLOGIE promotes interdisciplinary approaches, integrating insights from various medical fields to enhance the management of rheumatic diseases.
Recent publications in AKTUELLE RHEUMATOLOGIE indicate several emerging themes that reflect the evolving landscape of rheumatology research. These trends highlight the journal's responsiveness to contemporary challenges in the field.
  1. Telemedicine and Digital Health:
    There is a notable increase in studies exploring telemedicine and digital health interventions, particularly in response to the COVID-19 pandemic, emphasizing their role in enhancing patient care and accessibility.
  2. Microbiome Research in Rheumatology:
    An emerging focus on the relationship between the microbiome and rheumatic diseases is evident, with research investigating how gut health may influence disease activity and treatment responses.
  3. Gender Differences in Rheumatic Diseases:
    Recent papers are increasingly addressing the impact of gender on disease presentation, treatment efficacy, and outcomes, acknowledging the necessity of gender-sensitive approaches in rheumatology.
  4. Personalized Medicine and Biomarkers:
    Research on personalized medicine, including the identification of biomarkers for predicting disease progression and treatment responses, is gaining traction, reflecting a shift towards individualized patient care.
  5. Socioeconomic Factors in Disease Management:
    There is a growing interest in understanding how socioeconomic factors affect disease management, treatment adherence, and health outcomes in patients with rheumatic diseases.

Declining or Waning

While AKTUELLE RHEUMATOLOGIE continues to thrive in several research areas, some themes have seen a decline in focus over recent years. This section highlights those diminishing topics.
  1. Traditional Treatment Modalities:
    Research on conventional therapies, such as older DMARDs, appears to be waning as the field shifts towards biologics and targeted therapies, reflecting a growing emphasis on innovative treatment options.
  2. Historical Perspectives:
    Papers focusing on the historical aspects of rheumatology, while still valuable, are becoming less frequent as contemporary clinical research takes precedence in the journal's publications.
  3. Generalized Pain Management Strategies:
    Studies that provide broad, non-specific pain management strategies are declining in favor of more tailored, disease-specific approaches that address the unique needs of patients with rheumatic diseases.
  4. Basic Science Research:
    There seems to be a diminishing interest in purely basic science research without direct clinical implications, as the journal increasingly prioritizes studies that bridge the gap between laboratory findings and clinical application.

Similar Journals

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Fostering Global Collaboration in Rheumatology Research
Publisher: ELSEVIER SCI LTDISSN: 1521-6942Frequency: 4 issues/year

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, published by Elsevier, stands as a premier journal in the field of rheumatology, holding a prestigious Q1 ranking in both Medicine (miscellaneous) and Rheumatology categories as of 2023. With an ISSN of 1521-6942 and an E-ISSN of 1521-1770, the journal is dedicated to advancing clinical knowledge and practice through the dissemination of high-quality, peer-reviewed research. Since its inception in 1995, this journal has provided a platform for researchers, clinicians, and healthcare providers to share significant advancements, best practices, and innovative insights that shape the standards of care in rheumatology. The commitment to open access publishing reflects its mission to broaden the reach of critical research findings, ensuring that professionals across the globe can access valuable information in this vital field. The journal's impressive Scopus ranking, positioned at #10 out of 73 in Medicine-Rheumatology, alongside its notable impact factor, underscores its importance and influence in guiding clinical practice and policy in rheumatologic conditions. By engaging with this journal, readers can stay informed about emerging trends and evidence-based strategies that are crucial for improving patient outcomes.

BMC Rheumatology

Empowering research to transform rheumatic disease treatment.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

Egyptian Rheumatologist

Bridging gaps in autoimmune disease understanding.
Publisher: ELSEVIERISSN: 1110-1164Frequency: 4 issues/year

The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.

Pediatric Rheumatology

Exploring the forefront of child health and rheumatology.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

Reumatologia

Enhancing visibility of crucial research in Rheumatology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Archives of Rheumatology

Connecting global minds to transform rheumatologic care.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Exploring breakthroughs in rheumatology and immunology.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

Arthritis & Rheumatology

Exploring Breakthroughs in Arthritis and Immunology
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Reumatismo

Elevating understanding of rheumatic conditions through open access.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Rheumatology Advances in Practice

Bridging research and practice for better patient outcomes.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.